Literature DB >> 10652099

Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans.

A Sonneborn1, D P Bockmühl, M Gerads, K Kurpanek, D Sanglard, J F Ernst.   

Abstract

External signals induce the switch from a yeast to a hyphal growth form in the fungal pathogen Candida albicans. We demonstrate here that the catalytic subunit of a protein kinase A (PKA) isoform encoded by TPK2 is required for internal signalling leading to hyphal differentiation. TPK2 complements the growth defect of a Saccharomyces cerevisiae tpk1-3 mutant and Tpk2p is able to phosphorylate an established PKA-acceptor peptide (kemptide). Deletion of TPK2 blocks morphogenesis and partially reduces virulence, whereas TPK2 overexpression induces hyphal formation and stimulates agar invasion. The defective tpk2 phenotype is suppressed by overproduction of known signalling components, including Efg1p and Cek1p, whereas TPK2 overexpression reconstitutes the cek1 but not the efg1 phenotype. The results indicate that PKA activity of Tpk2p is an important contributing factor in regulating dimorphism of C. albicans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652099     DOI: 10.1046/j.1365-2958.2000.01705.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  83 in total

1.  Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans.

Authors:  A El Barkani; O Kurzai; W A Fonzi; A Ramon; A Porta; M Frosch; F A Mühlschlegel
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase Cpp1p of Candida albicans is independent of the MAP kinase Cek1p.

Authors:  K Schröppel; K Sprösser; M Whiteway; D Y Thomas; M Röllinghoff; C Csank
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  Efg1, a morphogenetic regulator in Candida albicans, is a sequence-specific DNA binding protein.

Authors:  P Leng; P R Lee; H Wu; A J Brown
Journal:  J Bacteriol       Date:  2001-07       Impact factor: 3.490

4.  Fungicidal monoclonal antibody C7 interferes with iron acquisition in Candida albicans.

Authors:  Sonia Brena; Jonathan Cabezas-Olcoz; María D Moragues; Iñigo Fernández de Larrinoa; Angel Domínguez; Guillermo Quindós; José Pontón
Journal:  Antimicrob Agents Chemother       Date:  2011-04-25       Impact factor: 5.191

5.  Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans.

Authors:  Martin Zavrel; Olivia Majer; Karl Kuchler; Steffen Rupp
Journal:  Eukaryot Cell       Date:  2011-12-02

6.  Hyphal growth in Candida albicans requires the phosphorylation of Sec2 by the Cdc28-Ccn1/Hgc1 kinase.

Authors:  Amy Bishop; Rachel Lane; Richard Beniston; Bernardo Chapa-y-Lazo; Carl Smythe; Peter Sudbery
Journal:  EMBO J       Date:  2010-07-16       Impact factor: 11.598

7.  CAP1, an adenylate cyclase-associated protein gene, regulates bud-hypha transitions, filamentous growth, and cyclic AMP levels and is required for virulence of Candida albicans.

Authors:  Y S Bahn; P Sundstrom
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

8.  Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro.

Authors:  Angela A Sanchez; Douglas A Johnston; Carter Myers; John E Edwards; Aaron P Mitchell; Scott G Filler
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

9.  cAMP signaling in Aspergillus fumigatus is involved in the regulation of the virulence gene pksP and in defense against killing by macrophages.

Authors:  B Liebmann; S Gattung; B Jahn; A A Brakhage
Journal:  Mol Genet Genomics       Date:  2003-05-07       Impact factor: 3.291

10.  The cyclic AMP-dependent protein kinase a network regulates development and virulence in Aspergillus fumigatus.

Authors:  Burghard Liebmann; Meike Müller; Armin Braun; Axel A Brakhage
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.